Due: June 29, 2024 Development of innovative solutions to provide a safe, quantitative, portable, and repeatable odor delivery system of various chemical, biological, and explosive (CBE) threat materials from a Person-Borne Improvised Explosive Device (PBIED) Read More
Due: November 15, 2024 This Notice of Funding Opportunity (NOFO) invites applications for specialized Alcohol Research Centers using the P50 mechanism. The overall purpose of the NIAAA Alcohol Research Center program is to provide leadership Read More
Due: October 3, 2024 The intent of the FY24 TBIPHRP FPA is to accelerate the development of solutions to critical question(s) related to at least one sub-area within one of the three FY24 TBIPHRP FPA Read More
Due: September 17, 2024 Orthopaedic injuries have a profound impact on military readiness and return to work/activity/duty. In the military, extremity battle wounds comprise approximately 50% of injuries reported in the Department of Defense Trauma Read More
Due: August 30, 2024 Research supported by the Implementation Science Award is expected to have the potential for major, near-term impact that will accelerate the widespread adoption of evidence-based practices in prostate cancer care, prevention, Read More
Due: August 26, 2024 FPA-RM applications must describe a unifying, overarching question that will be investigated by a set of research projects to address a critical unmet need relevant to rare melanoma research and/or patient Read More
Due: August 13, 2024 The purpose of this Notice of Funding Opportunity (NOFO) is to solicit research designed to capacitate, transform, and scale the delivery of HIV testing, prevention, and care services through pharmacists and Read More
Due: August 13, 2024 The purpose of this Notice of Funding Opportunity (NOFO) is to stimulate translational efforts in developing and implementing accessibility devices or interventions that apply new technologies to address challenges faced by Read More
Due: July 28, 2024 The National Human Genome Research Institute aims to setup a research Consortium, ML/AI Tools to Advance Genomic Translational Research (MAGen), to collaboratively explore the feasibility of developing Machine Learning (ML) and Read More
Due: July 26, 2024 The goal is to leverage AI/ML tools to identify pharmacotherapeutic development candidates with lower toxicity and higher efficacy to prevent or treat SUDs. Molecules may include new chemical entities, investigational compounds, Read More
NTA is operated by the 501c(3) non-profit Advanced Technology International (ATI). National Technology Alliance (NTA) © 2024 - All rights reserved.